NOVEMBER 4, 2013

Company

SUPERNUS PHARMACEUTICALS, INC.

Filed

November 4, 2013

Accession Number

0001013594-13-000532

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →